Core Viewpoint - The company reported a decline in revenue and net profit for the first half of 2025, but there are signs of potential recovery in the third quarter due to improved sales performance in July [1][2] Financial Performance - In H1 2025, the company achieved revenue of 300 million yuan, a decrease of 16.51% year-on-year, and a net profit attributable to shareholders of 65.56 million yuan, down 33.99% year-on-year [1] - Q2 2025 revenue was 129 million yuan, a decline of 6.64% year-on-year, with a net profit of 7.18 million yuan, down 67.61% year-on-year [1][2] - The company's expense ratio increased, with a total expense ratio of 70.24% in H1 2025, up 12.04 percentage points year-on-year [2] Market and Product Performance - The decline in revenue was primarily attributed to weak consumer demand, although there was a notable improvement in Q2 compared to Q1 [2] - Revenue from Lingzhi spore powder products was 216 million yuan, down 17.79% year-on-year, while revenue from Dendrobium candidum products was 46.66 million yuan, down 24.25% year-on-year [3] - Internet sales showed growth, with revenue of 76.78 million yuan, an increase of 15.14% year-on-year [3] Strategic Initiatives - The company is expanding its market presence through flagship stores and traditional channels, with successful construction of flagship stores in several provinces [3] - A national strategic cooperation agreement was signed with Jiuzhoutong Pharmaceutical to enhance reach to retail pharmacies [3] - The company is focusing on new media channels, particularly influencer live streaming, to attract a younger customer demographic [3] Competitive Advantages - The company’s core competitive advantages include a full industry chain, superior variety breeding, and advanced processing technology for Lingzhi spore powder [4] - The company has established a comprehensive industry chain model and has developed 12 superior varieties, including 4 Lingzhi and 4 Dendrobium varieties [4] - Unique technologies for breaking and purifying Lingzhi spore powder ensure high absorption rates and product safety [4] Future Outlook - Due to slower-than-expected recovery in demand and rising expense ratios, the company has adjusted its revenue and profit forecasts for 2025-2027 [5] - Projected revenues for 2025, 2026, and 2027 are 697 million, 778 million, and 859 million yuan, respectively, with corresponding net profits of 138 million, 172 million, and 205 million yuan [5]
寿仙谷(603896):上半年互联网端表现较好 预计三季度业绩有望好转